HomeCompareQCEQPX vs VYM

QCEQPX vs VYM: Dividend Comparison 2026

QCEQPX yields 0.34% · VYM yields 2.37%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VYM wins by $7.6K in total portfolio value
10 years
QCEQPX
QCEQPX
● Live price
0.34%
Share price
$584.22
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.1K
Annual income
$35.00
Full QCEQPX calculator →
VYM
Vanguard High Dividend Yield ETF
● Live price
2.37%
Share price
$148.10
Annual div
$3.51
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$27.8K
Annual income
$272.94
Full VYM calculator →

Portfolio growth — QCEQPX vs VYM

📍 VYM pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodQCEQPXVYM
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, QCEQPX + VYM cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
QCEQPX pays
VYM pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

QCEQPX
Annual income on $10K today (after 15% tax)
$29.10/yr
After 10yr DRIP, annual income (after tax)
$29.75/yr
VYM
Annual income on $10K today (after 15% tax)
$201.60/yr
After 10yr DRIP, annual income (after tax)
$232.00/yr
At 15% tax rate, VYM beats the other by $202.25/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of QCEQPX + VYM for your $10,000?

QCEQPX: 50%VYM: 50%
100% VYM50/50100% QCEQPX
Portfolio after 10yr
$24.0K
Annual income
$153.97/yr
Blended yield
0.64%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

QCEQPX buys
0
VYM buys
0
No recent congressional trades found for QCEQPX or VYM in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricQCEQPXVYM
Forward yield0.34%2.37%
Annual dividend / share$2.00$3.51
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$20.1K$27.8K
Annual income after 10y$35.00$272.94
Total dividends collected$347.00$2.6K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: QCEQPX vs VYM ($10,000, DRIP)

YearQCEQPX PortfolioQCEQPX Income/yrVYM PortfolioVYM Income/yrGap
1← crossover$10,734$34.23$11,147$237.17$413.00VYM
2$11,520$34.34$12,404$242.33$884.00VYM
3$12,361$34.45$13,780$247.16$1.4KVYM
4$13,261$34.54$15,285$251.67$2.0KVYM
5$14,223$34.63$16,932$255.88$2.7KVYM
6$15,254$34.72$18,733$259.81$3.5KVYM
7$16,356$34.80$20,701$263.46$4.3KVYM
8$17,536$34.87$22,852$266.86$5.3KVYM
9$18,799$34.94$25,201$270.01$6.4KVYM
10$20,150$35.00$27,768$272.94$7.6KVYM

QCEQPX vs VYM: Complete Analysis 2026

QCEQPXStock

QCEQPX is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in QCEQPX shares.

Full QCEQPX Calculator →

VYMETF

Seeks to track the performance of the FTSE High Dividend Yield Index, which measures the investment return of common stocks of companies characterized by high dividend yields. Provides a convenient way to track the performance of stocks that are forecasted to have above-average dividend yields. Follows a passively managed, full-replication approach.

Full VYM Calculator →
📬

Get this QCEQPX vs VYM comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

QCEQPX vs SCHDQCEQPX vs JEPIQCEQPX vs OQCEQPX vs KOQCEQPX vs MAINQCEQPX vs VIGQCEQPX vs DGROQCEQPX vs HDV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.